Menu
GeneBe

rs863225190

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_001382391.1(CSPP1):c.2723del(p.Asn908MetfsTer2) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000723 in 1,521,688 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (โ˜…โ˜…). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: ๐‘“ 0.0000066 ( 0 hom., cov: 32)
Exomes ๐‘“: 0.000080 ( 0 hom. )

Consequence

CSPP1
NM_001382391.1 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 6.28
Variant links:
Genes affected
CSPP1 (HGNC:26193): (centrosome and spindle pole associated protein 1) This gene encodes a centrosome and spindle pole associated protein. The encoded protein plays a role in cell-cycle progression and spindle organization, regulates cytokinesis, interacts with Nephrocystin 8 and is required for cilia formation. Mutations in this gene result in primary cilia abnormalities and classical Joubert syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Apr 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-67164395-GA-G is Pathogenic according to our data. Variant chr8-67164395-GA-G is described in ClinVar as [Pathogenic]. Clinvar id is 217642.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-67164395-GA-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CSPP1NM_001382391.1 linkuse as main transcriptc.2723del p.Asn908MetfsTer2 frameshift_variant 24/31 ENST00000678616.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CSPP1ENST00000678616.1 linkuse as main transcriptc.2723del p.Asn908MetfsTer2 frameshift_variant 24/31 NM_001382391.1

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
151868
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000796
AC:
109
AN:
1369820
Hom.:
0
Cov.:
22
AF XY:
0.0000816
AC XY:
56
AN XY:
686570
show subpopulations
Gnomad4 AFR exome
AF:
0.0000316
Gnomad4 AMR exome
AF:
0.000136
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000255
Gnomad4 SAS exome
AF:
0.0000719
Gnomad4 FIN exome
AF:
0.000189
Gnomad4 NFE exome
AF:
0.0000767
Gnomad4 OTH exome
AF:
0.000105
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
151868
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74150
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000113

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Joubert syndrome 21 Pathogenic:2
Pathogenic, criteria provided, single submitterresearchUW Hindbrain Malformation Research Program, University of WashingtonFeb 23, 2015- -
Pathogenic, criteria provided, single submitterclinical testingInvitaeDec 02, 2022The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 217642). This premature translational stop signal has been observed in individual(s) with Joubert syndrome (PMID: 24360808). This sequence change creates a premature translational stop signal (p.Asn903Metfs*2) in the CSPP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CSPP1 are known to be pathogenic (PMID: 24360807, 24360808). -
not provided Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingGeneDxJan 05, 2022Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24360808, 27894351) -
Pathogenic, criteria provided, single submitterclinical testingInstitute of Medical Genetics and Applied Genomics, University Hospital TรผbingenOct 23, 2020- -
CSPP1-related condition Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesNov 29, 2023The CSPP1 c.2708delA variant is predicted to result in a frameshift and premature protein termination (p.Asn903Metfs*2). This variant has been reported in individuals with Joubert syndrome (Tuz et al 2014. PubMed ID: 24360808; Shaheen et al 2016. PubMed ID: 27894351). This variant is reported in 0.012% of alleles in individuals of Latino descent in gnomAD. Frameshift variants in CSPP1 are expected to be pathogenic. This variant is interpreted as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs863225190; hg19: chr8-68076630; API